These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23517282)

  • 1. Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors.
    Rosa-Bray M; Wisdom C; Wada S; Johnson BR; Grifols-Roura V; Grifols-Lucas V
    Vox Sang; 2013 Aug; 105(2):108-15. PubMed ID: 23517282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of plasmapheresis on blood pressure in voluntary plasma donors.
    Rosa-Bray M; Wisdom C; Marier JF; Mouksassi MS; Wada S
    Vox Sang; 2015 Jan; 108(1):11-7. PubMed ID: 25169580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HELP Study Group.
    Seidel D; Armstrong VW; Schuff-Werner P
    Eur J Clin Invest; 1991 Aug; 21(4):375-83. PubMed ID: 1936104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
    Julius U; Metzler W; Pietzsch J; Fassbender T; Klingel R
    Int J Artif Organs; 2002 Dec; 25(12):1180-8. PubMed ID: 12518963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
    Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for increased cholesterol values in blood donors].
    Dengler T; Kasulke D; Oehmig R; Kellner S; Fürst G
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):226-31. PubMed ID: 7496121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood iron stores reduction affects lipoprotein status--a potential benefit of blood donation.
    Jadrić R; Hasić S; Kiseljaković E; Corić J; Prnjavorac B; Winterhalter-Jadrić M
    Med Glas (Zenica); 2011 Feb; 8(1):146-50. PubMed ID: 21263413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation.
    Schuff-Werner P; Gohlke H; Bartmann U; Baggio G; Corti MC; Dinsenbacher A; Eisenhauer T; Grützmacher P; Keller C; Kettner U
    Eur J Clin Invest; 1994 Nov; 24(11):724-32. PubMed ID: 7890009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia.
    Yokoyama S; Hayashi R; Satani M; Yamamoto A
    Arteriosclerosis; 1985; 5(6):613-22. PubMed ID: 3865648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal and recovery of cholesterol in thermofiltration.
    Takeyama Y; Malchesky PS; Cressman MD; Yamashita M; Horiuchi T; Usami M; Koo AP; Pence G; Nose Y
    Int J Artif Organs; 1988 May; 11(3):201-8. PubMed ID: 3403058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between population density and blood lipid levels in Dutch blood donors.
    de Groot R; Hoenink JC; Mackenbach JD; den Braver NR; Pinho MGM; Brassinga D; Prinsze FJ; Timmer TC; de Kort WLAM; Brug J; van den Hurk K; Lakerveld J
    Int J Health Geogr; 2019 Feb; 18(1):3. PubMed ID: 30717744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
    Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of haemoglobin monitoring in apheresis plasma donors: A retrospective cohort study in Québec, Canada.
    Lewin A; Germain M; Renaud C; Robitaille N; Latour C
    Vox Sang; 2023 Dec; 118(12):1041-1045. PubMed ID: 37673797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary heart disease risk factors among blood donors in northwest Ethiopia.
    Gebre-Yohannes A; Rahlenbeck SI
    East Afr Med J; 1998 Sep; 75(9):495-500. PubMed ID: 10493048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.